Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Gene Expression Analysis Market to be Valued Close to $11 Billion by 2025 | Million Insights


News provided by

Million Insights

02 May, 2018, 10:40 GMT

Share this article

Share toX

Share this article

Share toX

FELTON, California, May 2, 2018 /PRNewswire/ --

The global Gene Expression Market is estimated to reach USD 11.3 billion by 2025. Market is also expected to grow at a decent rate over the forecast period driven by rising number of cancer patients, facilities for financial funding, decreased cost of sequencing, and high concentration on research & development. In emerging economies, the industry offers advantageous opportunities for growth with rising concentration on adoption and precision as well as personalization in medicines. However, currency devaluation in developing economies and initial capital investment of different instruments are considered as restraint as well as challenge for the industry.

The gene expression is a set of steps for a functional genetic code product occur in the synthesis, with the support of the data coded on genes. The process is prominent in multi cellular organisms as well as bacteria such as eukaryotes or prokaryotes, which ensure the creation of machinery macro molecular of their life.

In context with the consumables of gene expressions, the industry is classified into DNA chips and reagents. The segment of reagent held the largest revenue share of consumables in the industry. This segment is anticipated to witness high growth influenced by increasing number of service center for sequencing, research & development with financial funding, and rising installation number of analysis instruments.

The overall market can be segmented by technologies into Northern Blotting, SAGE, Micro array, DNA, NGS, and PCR. The NGS technological segment is considered to be the rapidly growing sector. However, the PCR technology held the largest revenue share over the forecast period. The rapid growth of NGS technology is influenced by rise in large scale gene expression demand, technological advancement & improvised throughput & speed, wide spectrum of applications, and in depth knowledge of sequencing DNA.

Browse 185 page research report with TOC on "Global Gene Expression Analysis Market" at: https://www.millioninsights.com/industry-reports/gene-expression-analysis-market 

The services offered by this industry are classified as bio informatics solutions and profiling services. Profiling services of gene expressions occupy the largest industry share. The profiling services provide essential insights in terms of personalized medicine, determining drug, and enhanced diagnosis of disease. Aforementioned factor would drive the demand for profiling services over the forecast period.

The genetic code expression includes translation and transcription process. The translation process protein from RNA is a sequence occurs in the protein-based synthesis on coding genes data. The transcription from DNA to RNA can be described to the creation of coples RNA of DNA with the support of the RNA enzyme polymerase. The regulations of genetic code refer to its functions, renders cell control through structure, versatility & differentiation of cellular substance, and morphogenesis. The alteration in the overall process can be possible with such as modification of proteins after translation process, and splicing of RNA.

The profiling primarily refers to the set of step used to measure the expression of numerous genetic codes in order to determine the functions related to cellular. This process can be helpful to determine the differences in molecular base of phenotypic and offers the target GE selection for research purpose. There are various techniques used for this analysis such as transcriptase sequencing, analysis of micro array, PCR based real time profiling, and serial analysis of GE among others.

However, reagents are the chemical substances required in the studies undertaken to identify the pattern. Traditionally available reagents kits include hybridization, Taq Man assay, sample labeling and amplification, sample preparation and isolation and other significant kits.

The North America industry is estimated to hold the largest share, followed by Asia Pacific and Europe. The Asia Pacific region is estimated for the rapid growth over the forecast period. The growth in this region is influenced by increasing gene test popularity, government concern to improve healthcare with laws & regulation, and rising agriculture research activity.

The vital factors influencing the growth and contribution of aforementioned region include development of databases, increasing R & D, and continuous advancement & innovation in technology across the world. Rising initial funding and investment for research in genetic by government as well as the growing awareness & popularity of gene expressions is expected to shift demand. Recently, classified systems of GE have determined a cancer subtype aggressive colon with features like mesenchymal, which ensures EMT of tumor cells.

Some of the major players competing in this industry are Agllent Technologies, Bio Rad Laboratories, Thermo Fisher Scientific, Qiagen N.V., Illunia Inc., Affymetrix Inc., and other prominent players. High initial cost for instruments as well as lack of expertise & skilled technician would hinder the growth. However, with numerous advantages and rising interest for precise medicines, the growth & scope of new studies would influence the adoption of reagents.

Browse reports of similar category available with Million Insights: 

  • Orthobiologics Market 
  • Next Generation Sequencing Market 
  • Proteomics Market 
  • Biophotonics Market 

Process Outlook (Revenue, USD Million; 2014 - 2025) 

    • Sample Collection

    • Purification

    • cDNA synthesis & conversion

    • PCR Analysis

    • Data analysis & interpretation

Product Outlook (Revenue, USD Million; 2014 - 2025) 

    • Kits & Reagents

    • DNA Chips

    • Others

Capacity Outlook (Revenue, USD Million; 2014 - 2025) 

    • Low- to Mid- Plex

    • High-Plex

Technique Category Outlook (Revenue, USD Million; 2014 - 2025) 

    • RNA Expression

            • Northern Blotting

            • DNA Microarrays

            • PCR Techniques

            • RNA-Seq

    • Promoter Analysis

            • In vitro Transcription/Nuclear Run-On Assays

            • Gel Shift Assays

            • Chromatin Immunoprecipitation (ChIP)

    • Protein Expression & Posttranslational Modification Analysis

            • Western Blotting

            • 2-D Gel Electrophoresis

            • Immunoassays

            • Mass Spectrometry

Application Outlook (Revenue, USD Million; 2014 - 2025) 

    • Drug Discovery & Development

    • Clinical Diagnostics

    • Biotechnology & Microbiology

    • Others

Regional Outlook (Revenue, USD Million; 2014 - 2025) 

    • North America

        • U.S.

        • Canada

    • Europe

        • Germany

        • UK

    • Asia Pacific

        • Japan

        • China

    • Latin America

        • Brazil

    • Middle East and Africa (MEA)

        • South Africa

About Million Insights: 

Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place, that will enable you to compare data points, before you make a purchase. Enabling informed buying, is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.


Contact:
Ryan Manuel
Research Support Specialist, USA
Million Insights
Phone: +1-408-610-2300
Toll Free: 1-866-831-4085
Email: sales@millioninsights.com

Web: https://www.millioninsights.com/

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.